Starling Oncology (STLNW) Receivables - Other (2020 - 2026)
Starling Oncology's (STLNW) quarterly Receivables - Other came in at $360000.0 in Q2 2026, up 30.43% on a YoY basis from $276000.0 in Q2 2025, and down 72.64% quarter-over-quarter from $1.3 million in Q1 2026.
Powered by 
Analysis
Starling Oncology (STLNW) Receivables - Other (2020 - 2026) Analysis & Trends
Starling Oncology (STLNW) has reported Receivables - Other for 7 consecutive years, with $360000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Other rose 30.43% year-over-year to $360000.0; the trailing twelve-month figure through Jun 2026 stood at $360000.0 (up 30.43% YoY), and the FY2025 full-year result was $322000.0, down 6.94% from the prior year.
- Receivables - Other slipped to $360000.0 in Q2 2026 per STLNW's latest filing, from $1.3 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.3 million in Q1 2026 and bottomed at -$17000.0 in Q4 2025.
- Historically, Receivables - Other has averaged $415555.6 across 5 years, with a median of $359000.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Receivables - Other jumped 6295.0% in 2022, then tumbled 113.79% in 2024.
- Over 5 years, Receivables - Other stood at $58000.0 in 2022, then soared by 50.0% to $87000.0 in 2023, then plunged by 113.79% to -$12000.0 in 2024, then tumbled by 41.67% to -$17000.0 in 2025, then soared by 2217.65% to $360000.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $360000.0, $1.3 million, and -$17000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 360,000.00 |
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | -17,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 276,000.00 |
| Mar 31, 2025 | 346,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | 358,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 87,000.00 |
| Sep 30, 2023 | 464,000.00 |
| Jun 30, 2023 | 499,000.00 |
| Mar 31, 2023 | 428,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 559,000.00 |
| Jun 30, 2022 | 422,000.00 |
| Mar 31, 2022 | 1.28 Mn |
| Dec 31, 2021 | 473,000.00 |
| Sep 30, 2021 | -71,000.00 |